2025 annual financial data

Seres Therapeutics 2025 Net margin

Direct answer

Net margin was 721.93%.

Operating income was -93.97M USD and net income was 5.7M USD.
Operating cash flow was 1.12M USD.

Get free Seres Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
789,000 USD
Operating income
-93.97M USD
Net income
5.7M USD
Operating cash flow
1.12M USD